The Struggles and Advocacy for Medical Marijuana in the Philippines
Introduction to Julia Cunanan’s Battle with Epilepsy
Just seven years old, Julia Cunanan has traversed a medical maze that many adults have yet to face. Diagnosed with Dravet syndrome—an intractable form of epilepsy—she has been prescribed seven different anti-seizure medications, including phenobarbital and Valproic acid. While Julia’s current treatment regimen has fortunately been trimmed down to two drugs, the ordeal has left her with significant side effects, affecting her kidney, liver, and pancreas functions.
Her mother, Donnabel Cunanan, a dentist who stands by her daughter’s side, shares her anguish as she recounts moments when Julia was hospitalized due to bleeding in her pancreas caused by the very medications meant to help her. “The seizures are still there, the damage and the pain are really harmful,” Donnabel recounts, highlighting that Julia experiences up to 1,000 seizures daily. Observing the developmental delays in Julia’s growth, she feels the weight of responsibility to explore alternative treatments.
The Advocacy for Medical Cannabis
Donnabel has become a leading voice in the Philippines for medical marijuana, serving as a spokesperson and founding member of the Philippine Cannabis Compassion Society (PCCS). The advocacy group fights for the legalization of medical cannabis in a country renowned for its stringent drug policies, which were heavily intensified under President Rodrigo Duterte’s administration since 2016.
Despite heavy criticism from local and international communities regarding the government’s aggressive anti-drug campaign, there is a burgeoning movement advocating for medical marijuana. As Chuck Manansala from the Filipino Medical Cannabis Research Center notes, the goal is not merely legalization but to make cannabis—a substance already recognized as a medical option—accessible to patients in need.
The Legal Landscape: Strict Regulations and Social Push
The backdrop of the Philippines’ drug policies is grim. Individuals caught possessing 500 grams or more of marijuana can be sentenced to life imprisonment and face substantial financial penalties under the Comprehensive Dangerous Drugs Act of 2002. Yet, a slow shift is occurring, with the discourse around cannabis moving towards potential medical acceptance.
In 2019, the World Health Organization (WHO) recommended reclassifying cannabis to allow for better access to medical applications, acknowledging its therapeutic potential. This global perspective is gradually influencing discussions within the Philippines.
Challenges with Access and Legislation
Current healthcare practices in the Philippines pose severe barriers for patients, especially those reliant on medical marijuana. As Donnabel explains, although a compassionate use administrative order exists, it primarily permits access to FDA-approved medications. For epilepsy patients like Julia, the solitary option is Epidiolex, a cannabis-derived drug that can cost upwards of $30,000 annually. This astronomical expense effectively prices out most patients in a country where the average family income hovers around $5,000 per year.
Access to medical marijuana remains complicated, requiring a lengthy permit process and compliance with an outdated administrative order from 1992. Patients are often left no choice but to resort to illegal means for relief.
The Shadow of Injustice: Drug Policies and Societal Impact
The culture surrounding drug possession in the Philippines is grim, with lethal consequences for perceived violations. Prior to the death penalty’s abolition in 2006, even minor drug offenses were met with extreme punishment. Today, under the specter of Duterte’s drug war, patients and advocates find themselves ensnared in a system that criminalizes their search for relief.
Cunanan notes, “No Filipino has accessed medical cannabinoids legally, except those who flew abroad,” illustrating the desperate measures that patients are forced to consider. The lack of accessible and affordable medical cannabis keeps patients in a dangerous cycle—one that reinforces the need for reform.
Changing Attitudes and the Role of Social Media
Social media has become a double-edged sword in the conversation around medical marijuana. While it has amplified advocacy efforts by organizations like PCCS and ignited public interest, it has also led to the spread of misinformation and unrealistic claims about cannabis’ benefits. Misconceptions around marijuana being a “wonder drug” furor the dialogue, making it all the more important for patient education to be prioritized within medical narratives.
Donnabel Cunanan passionately advocates for changing perceptions of patients like her daughter, insisting they be seen as individuals in need of care rather than criminals.
Hope Amidst Legislative Challenges
Despite ongoing struggles, there remains a flicker of hope for advocates pushing for medical marijuana legislation in the Philippines. Efforts have led to discussions of bills aimed at legalizing medicinal use, which some legislators have openly debated. However, the legislative landscape has been torturous, marred by mixed messages from the government and public representatives.
As discussions linger, advocates remain vigilant, hopeful that upcoming legislative sessions will finally translate into concrete action that addresses the urgent needs of patients relying on medical marijuana. “We hope and pray that the promises made by legislators would translate into action,” Donnabel states, embodying the tenacity that characterizes the fight for compassionate care in an often unforgiving society.
Conclusion: A Complicated Journey Towards Change
The story of Julia Cunanan encapsulates the broader struggles of countless families navigating a healthcare system fraught with challenges. It illustrates the tension between traditional drug policies and the emerging recognition of cannabis as a viable medical option. Each perspective offers a glimpse into the profound human impact of policy decisions, urging lawmakers to view medical marijuana through the lens of compassion and patient needs.